This inventor holds 1 USPTO granted patent. Top assignee: Polaris Pharmaceuticals, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Chau-Ting Yeh: Innovator in Arginine Deprivation Therapy
Introduction: Chau-Ting Yeh is a notable inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of medical research, particularly in therapies related to arginine deprivation. His work is essential in advancing treatment options for various health conditions.
Latest Patents: Chau-Ting Yeh holds a patent titled "Methods and Kits for Identifying Subjects Responsive to Arginine Deprivation Therapy." This patent reflects his innovative approach to identifying patients who may benefit from specific therapeutic interventions. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights: Yeh is currently employed at Polaris Pharmaceuticals, Inc., where he continues to develop and refine therapeutic methods. His role at the company allows him to collaborate with other experts in the field, enhancing the impact of his research.
Collaborations: Throughout his career, Chau-Ting Yeh has worked alongside talented colleagues, including Chun-Hung Chou and Yu-De Chu. These collaborations have fostered a productive environment for innovation and research.
Conclusion: Chau-Ting Yeh's contributions to the field of arginine deprivation therapy highlight his dedication to improving patient outcomes through innovative research. His work at Polaris Pharmaceuticals, Inc. and his patent demonstrate his significant role in advancing medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile